These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 20505743)

  • 1. Antenatal magnesium sulfate and the postnatal response of the ductus arteriosus to indomethacin in extremely preterm neonates.
    Katayama Y; Minami H; Enomoto M; Takano T; Hayashi S; Lee YK
    J Perinatol; 2011 Jan; 31(1):21-4. PubMed ID: 20505743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of indomethacin tocolysis on the postnatal response of the ductus arteriosus to indomethacin in extremely low birth weight infants.
    Cordero L; Nankervis CA; Gardner D; Giannone PJ
    J Perinatol; 2007 Jan; 27(1):22-7. PubMed ID: 17053778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indomethacin prophylaxis or expectant treatment of patent ductus arteriosus in extremely low birth weight infants?
    Cordero L; Nankervis CA; Delooze D; Giannone PJ
    J Perinatol; 2007 Mar; 27(3):158-63. PubMed ID: 17251986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antenatal exposure to magnesium sulfate and the incidence of patent ductus arteriosus in extremely low birth weight infants.
    del moral T; Gonzalez-Quintero VH; Claure N; Vanbuskirk S; Bancalari E
    J Perinatol; 2007 Mar; 27(3):154-7. PubMed ID: 17314984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal reversed constrictive effect of indomethacin and postnatal delayed closure of the ductus arteriosus following administration of transplacental magnesium sulfate in rats.
    Toyoshima K; Momma K; Nakanishi T
    Neonatology; 2009; 96(2):125-31. PubMed ID: 19279396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immediate clinical outcomes in preterm neonates receiving antenatal magnesium for neuroprotection.
    Basu SK; Chickajajur V; Lopez V; Bhutada A; Pagala M; Rastogi S
    J Perinat Med; 2011 Aug; 40(2):185-9. PubMed ID: 21834608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal impairment associated with indomethacin treatment for patent ductus arteriosus in extremely preterm neonates--is postnatal age at start of treatment important?
    Srinivasjois RM; Nathan EA; Doherty DA; Patole SK
    J Matern Fetal Neonatal Med; 2006 Dec; 19(12):793-9. PubMed ID: 17190690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.
    Chotigeat U; Jirapapa K; Layangkool T
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin.
    Itabashi K; Ohno T; Nishida H
    J Pediatr; 2003 Aug; 143(2):203-7. PubMed ID: 12970633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.
    Jaillard S; Larrue B; Rakza T; Magnenant E; Warembourg H; Storme L
    Ann Thorac Surg; 2006 Jan; 81(1):231-4. PubMed ID: 16368371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of antenatal indomethacin on ductus arteriosus early closure and on adverse outcomes in preterm neonates.
    Doni D; Paterlini G; Locatelli A; Arnoldi S; Magri MC; Bernasconi D; Valsecchi MG; Tagliabue PE
    J Matern Fetal Neonatal Med; 2020 Feb; 33(4):645-650. PubMed ID: 29986620
    [No Abstract]   [Full Text] [Related]  

  • 12. Is the prophylaxis of patent ductus arteriosus useful in extremely premature infants?
    Bersani I; De Carolis MP; Lacerenza S; De Rosa G; Fusco FP; Cota F; Romagnoli C
    Turk J Pediatr; 2011; 53(2):187-93. PubMed ID: 21853657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent pulmonary hypertension in a premature newborn after 16 hours of antenatal indomethacin exposure.
    Tarcan A; Gürakan B; Yildirim S; Ozkiraz S; Bilezikçi B
    J Perinat Med; 2004; 32(1):98-9. PubMed ID: 15008397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety of prolonged indomethacin therapy.
    Savage AH; Anderson BL; Simhan HN
    Am J Perinatol; 2007 Apr; 24(4):207-13. PubMed ID: 17447185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment strategies to prevent or close a patent ductus arteriosus in preterm infants and outcomes.
    Laughon M; Bose C; Clark R
    J Perinatol; 2007 Mar; 27(3):164-70. PubMed ID: 17251985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose indomethacin for patent ductus arteriosus closure: how strong is the evidence?
    Manzar S
    Pediatrics; 2006 May; 117(5):1863; author reply 1863-4. PubMed ID: 16651359
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical aspects of very-low-birthweight infants showing reopening of ductus arteriosus.
    Uchiyama A; Nagasawa H; Yamamoto Y; Tatebayashi K; Suzuki H; Yamada K; Arai M; Kohno Y
    Pediatr Int; 2011 Jun; 53(3):322-7. PubMed ID: 20854286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33 weeks of gestation.
    Sperandio M; Beedgen B; Feneberg R; Huppertz C; Brüssau J; Pöschl J; Linderkamp O
    Pediatrics; 2005 Dec; 116(6):1361-6. PubMed ID: 16322159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orogastric and intravenous indomethacin administration to very premature neonates with patent ductus arteriosus: population pharmacokinetics, absolute bioavailability, and treatment outcome.
    Al Za'abi M; Donovan T; Tudehope D; Woodgate P; Collie LA; Charles B
    Ther Drug Monit; 2007 Dec; 29(6):807-14. PubMed ID: 18043480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic indomethacin in extremely premature infants between 23 and 24 weeks gestation.
    Yoshimoto S; Sakai H; Ueda M; Yoshikata M; Mizobuchi M; Nakao H
    Pediatr Int; 2010 Jun; 52(3):374-7. PubMed ID: 19843236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.